I am a
Home I AM A Search Login

Migraine/Headache

Share this

ASIC3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain.

There is a major unmet need to develop new therapies for migraine. We have previously demonstrated the therapeutic potential of the acid sensing ion channel (ASIC) blockade in migraine, via an ASIC1 mechanism. ASIC3 is expressed in the trigeminal ganglion and its response is potentiated by nitric oxide that can trigger migraine attacks in patients, and thus we sought to explore the potential therapeutic effect of ASIC3 blockade in migraine.

Learn More >

HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine?

This article reviews current headache disability measures and clinical need, as well as presenting the rationale for a new measure addressing work-related disability in migraine patients and the steps devoted to this aim.

Learn More >

Evidence Regarding Medication Overuse Headache in Children and Adolescents: Protocol for a Systematic Review.

This proposed systematic review will identify the existing evidence on medication-overuse headache in children and adolescents.

Learn More >

Prevalence of Facial Pain and Headache in Sweden.

To compare the prevalence of facial pain and headache across various regions in Sweden.

Learn More >

Ubrogepant for the Treatment of Migraine.

Ubrogepant is an oral, small-molecule calcitonin gene-related peptide receptor antagonist for acute migraine treatment.

Learn More >

Mindfulness as one component of an integrative approach to migraine treatment in clinical practice: companion editorial.

Learn More >

HLA class I alleles are associated with clinic-based migraine and increased risks of chronic migraine and medication overuse.

We aimed to evaluate associations of human leukocyte antigen variants with migraine or headache in hospital and population-based settings.

Learn More >

60 Years and Counting – Headache’s Brilliant Diamond Anniversary.

Learn More >

Atypical Migraine in Clinical Practice: Are We Missing It?

In countries like India, many migraine patients presenting to primary care clinics fail to fulfill standard (ICHD 3) migraine diagnostic criteria. Since they do not present with typical ICHD 3 migraine diagnostic symptoms, it is necessary to define the criteria for atypical migraine. This would ensure that the patients receive the right treatment approach, both non-pharmacological and pharmacological. Looking for triggers, family history, activity affected and absolute normality in between attacks, past episodes of episodic syndromes, prodromal and oculonasal autonomic symptoms will help in identifying the migraine origin of these headaches.

Learn More >

Association of Hormonal Contraceptive Use with Headache and Temporomandibular Pain: The OPPERA Study.

To determine the relationship between hormonal contraceptive (HC) use and painful symptoms, particularly those associated with headache and painful temporomandibular disorders (TMD).

Learn More >

Search